WorldLII Home | Databases | WorldLII | Search | Feedback

Generic Top Level Domain Name (gTLD) Decisions

You are here:  WorldLII >> Databases >> Generic Top Level Domain Name (gTLD) Decisions >> 2000 >> [2000] GENDND 377

Database Search | Name Search | Recent Decisions | Noteup | LawCite | Help

PHAR-MOR, INC. v. PHAR-MOR, INC. [2000] GENDND 377 (26 May 2000)


National Arbitration Forum


P. O. Box 50191
Minneapolis, Minnesota 55405 USA
www.arbitration-forum.com


PHAR-MOR, INC.
Complainant,

vs.

EPICENTER COMMUNICATIONS, INC.,
Respondent.

MAJORITY DECISION

Forum File No.: FA0003000094363

The above entitled matter came on for an administrative hearing on May 24, 2000 before Richard B. Wickersham, Andrew F. Christie and Herman D. Michels (Chair), the Arbitrators assigned to this matter, on the complaint of Phar-Mor, Inc. (Complainant), represented by David R. Posteraro, Esq. (Roetzel & Andress, attorneys for Complainant) against Epicenter Communications, Inc. (Respondent), represented by Douglas P. Ferguson, Esq. Upon the written submitted record, including the Complaint and the Response to the Complaint the following Majority Decision is rendered:

PROCEDURAL FINDINGS

Domain Name: PHARMORE.COM

Domain Name Registrar: Network Solutions, Inc.

505 Huntmar Park Drive

Herndon, Virginia 20170

Domain Name Registrant: Epicenter Communications, Inc.

Date of Domain Name Registration: April 12, 1999

Date Complaint Filed: March 27, 2000

Date Response Filed: April 19, 2000

After reviewing the Complaint and determining it to be in administrative compliance, the National Arbitration Forum (the "Forum") forwarded the Complaint to Respondent in compliance with Rule 2(a) and the administrative proceeding was commenced pursuant to Rule 4(c) in compliance with Rule 4(d). The Forum immediately notified Network Solutions, Inc., the INTERNET CORPORATION FOR ASSIGNED NAMES AND NUMBERS ("ICANN") and Respondent that the administrative proceeding had commenced. Respondent has submitted a Response to the Forum within twenty (20) days pursuant to Rule 5(a) which time has now expired. The Complaint and the Response and all Exhibits were forwarded to the Arbitrators for decision.

On April 12, 1999, Respondent registered the domain name PHARMORE.COM with the domain name registrar Network Solutions, Inc., the entity that is the registrar of the domain name. Network Solutions, Inc. verified that Respondent is the registrant for the domain name PHARMORE.COM and by registering its domain name with Network Solutions, Inc., Respondent agreed to resolve any disputes regarding its domain name through ICANN's Rules for Uniform Domain Name Dispute Resolution policy. Neither the Complainant nor the Respondent has contested the jurisdiction of the Forum or the three Arbitrators assigned to resolve this controversy.

FINDINGS OF FACT

    1. Complainant is the owner of U.S. Trademark Registration Number 1, 994,585 for the trademark PHAR-MOR. Since January 1983, Complainant has been using the trademark PHAR-MOR in connection with various goods and services, including artificial sweeteners, unexposed photographic film, dentifrices, non-medicated hair care preparations, essential oils for personal use, cosmetics, sun tan preparations, pharmaceutical preparations, razors, dental apparatus and instruments, namely dental floss, disposable diapers, cotton balls and retail store services in the field of drug store products, health and cosmetic preparations and general merchandise. Initially the mark was used for retail store services in the field of drug store products, health and cosmetic preparations and general merchandise. As the business grew, so did Claimant's usage of the PHAR-MOR trademark. Over the years the PHAR-MOR trademark has expanded to include numerous private label consumer products, pharmaceutical goods, as well as establish Claimant's presence on the Internet.
    2. Claimant has expended significant time, money and effort to establish public recognition of its PHAR-MOR mark as identifying it as the source of numerous high quality goods and service. Claimant uses this trademark in advertising and promoting both in print and electronic form the sale of its goods throughout the United States. Claimant advertises its goods and services under the PHAR-MOR mark and operates one hundred and thirty nine [139] retail stores in twenty four [24] states. In addition, Claimant operates three hundred two [302] retail stores. Claimant's current advertising budget for marketing its goods and services under the PHAR-MOR mark is twenty two million five hundred thousand [$22,500,000.00] dollars per annum. As a result of these efforts Claimant has established substantial good will and consumer recognition of the PHAR-MOR trademark, which has become one of Claimant's most valuable assets.
    3. Claimant's trademark application for the mark PHAR-MOR was filed with the United States Patent and Trademark Office on May 16, 1983. This mark was registered on the principal register on August 14, 1984 and issued the registration number 1,290,511. Complainant filed a second trademark registration on December 21, 1994, to expand the protection of the PHAR-MOR mark to other goods and services. This mark was registered on the principal register on August 20, 1994 and issued the registration number 1,994,585. These two marks are in full force and effect and are currently utilized in all aspects of Claimant's business. Complainant has the exclusive right to use and to license the PHARMOR mark.
    4. On February 24, 1996, Claimant expanded its application of the PHAR-MOR mark to the Internet, when it launched its website, WWW.PHARMOR.COM. Through this website, Claimant sells retail products, operates an on-line pharmacy, disseminates health and pharmaceutical information, maintains a portal devoted to health and medicine and offers various other health related services. As Claimant's website is an integral part of its business, third-party usage of confusingly similar domain name would cause irreparable harm to Claimant.
    5. Respondent's domain name PHARMORE.COM is confusingly similar to Claimant's trademark or service mark in which Complainant has all rights, title and interests and consumers are likely to be confused into believing that there is some affiliation, connection, sponsorship, approval or association between Respondent and Claimant, when in fact no such affiliation or association exists. See Rule 4(a)(i).
    6. Respondent does not have any rights or legitimate interests in respect to the domain name PHARMORE.COM. See Rule 4(a)(ii).
    7. Respondent has not demonstrated any rights to and legitimate interest in the domain name PHARMORE.COM. Respondent has not made any active use of the said domain name and tended no evidence of any preparations towards such use. Moreover, there is no evidence that Respondent has been commonly known by the domain name PHARMORE.COM nor is there any evidence that Respondent is making a legitimate non-commercial or fair use of the domain name without intent for commercial gain to misleadingly divert customers or to tarnish the trademark or service mark at issue.
    8. Respondent registered and used the domain name PHARMORE.COM in bad faith as evidenced by the fact that it registered the domain name on April 12, 1999 nearly sixteen years after Claimant's mark was registered by the United States Patent and Trademark Office and over two years after Claimant's registration of its domain name PHARMOR.COM on February 14, 1997. Claimant was therefore aware or should have been aware of the existence of Claimant's domain name. Moreover, the circumstances indicate that Respondent had registered or acquired the domain name PHARMORE.COM primarily for the purpose of selling, renting or otherwise transferring the domain name registration to Complainant who is the owner of the trademark or servicemark for valuable consideration in excess of Respondent's documented out-of-pocket costs directly related to the domain name. See Rule 4(a)(iii) and Rule 4(b)(i).
    9. Respondent's registration and use of the domain name PHARMORE.COM constitute an infringement of Complainant's rights in its PHARMOR mark and has caused and will continue to cause substantial and irreparable harm to Complainant and its business reputation and good will. Complainant therefore demanded that Respondent transfer the domain name PHARMORE.COM to Complainant.

CONCLUSION

The arbitrators Richard B. Wickersham, Andrew F. Christie, and Herman D. Michels certify that they have acted independently and have no known conflict of interest to serve as Arbitrators in this proceeding. Having been duly selected and being impartial and neutral, Richard B. Wickersham and Herman D. Michels, a majority of the Arbitrators, make the following findings and conclusions:

1. The domain name PHARMORE.COM registered by Respondent on April 12, 1999 with Network Solutions, Inc. the domain name registrar is confusingly similar to Complainant's mark PHARMOR, Claimant's registered trademark and service mark registered on the principal register of the United States Patent and Trademark Office by Complainant. Complainant has all rights and interest in said PHARMOR mark.

2. Respondent does not have any rights or legitimate interests in respect to the domain name PHARMORE.COM.

3. Respondent has registered and used the domain name PHARMORE.COM in bad faith.

DECISION

Based upon the above findings and conclusions and pursuant to Rule 4 (1) of the Rules of the Uniform Domain Name Dispute Resolution Policy and the National Arbitration Forum Supplemental Rules of ICANN's Uniform Domain Resolution Policy, Richard B. Wickersham and Herman D. Michels, a majority of the Arbitrators, Order that:

1. The domain name PHARMORE.COM registered by Respondent Epicenter Communications, Inc. be transferred forthwith to Complainant Phar-Mor, Inc., and

2. Respondent Epicenter Communications, Inc. shall cease and desist from any and all use of the domain name PHARMORE.COM.

For a Majority of the Arbitrators

__________________________________________

Herman D. Michels, Chair

Dated: May 26, 2000


WorldLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback
URL: http://www.worldlii.org/int/other/GENDND/2000/377.html